Invention Grant
- Patent Title: Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins
-
Application No.: US16196823Application Date: 2018-11-20
-
Publication No.: US11136365B2Publication Date: 2021-10-05
- Inventor: Justin Scheer , Wenjun Ouyang , Richard Vandlen , Philip E. Hass , Eric Gary Stefanich , Ganesh A. Kolumam , Xiaoting Wang , Jed Ross , Nicholas Van Bruggen
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Clark & Elbing LLP
- Agent Karen L. Elbing
- Main IPC: C07K14/54
- IPC: C07K14/54 ; C07K16/28 ; A61K38/20 ; A61K47/38 ; A61K38/00
Abstract:
The invention relates to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising the same, methods of making and methods of using the composition for the treatment of diseases. The invention also relates to IL-22 receptor associated reagents and methods of use thereof.
Public/Granted literature
- US20190177388A1 IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE Public/Granted day:2019-06-13
Information query
